Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Addivant was a leading global producer of specialty additives, including antioxidants, light stabilizers, and flame retardants, serving a wide range of industries including healthcare and life sciences. The company provided high-performance additives specifically designed for medical-grade plastics, surgical instruments, and pharmaceutical packaging, ensuring material stability and safety in sensitive medical environments. Notable products included the WESTON 705 liquid antioxidant, which met stringent global regulatory standards for food contact and medical applications. In 2020, Addivant was merged with SI Group under the ownership of SK Capital Partners to create a consolidated global leader in performance additives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Addivant.